Policy

Screening aims to identify people likely to develop a disease – it is widely used in e.g. cancer prevention and prenatal/newborn screening.

Genetics also determine health. In future, genomics will become increasingly important, as nearly every disease has constitutive and/or acquired genomic components.

Cancer screening

The Commission supports the development of cancer screening programmes in the EU for breast, cervical and colorectal cancer.

Prenatal screening

Prenatal screening policies are different across Europe (see European perinatal health reportpdf).

A project is planned to evaluate the different newborn screening practices for rare disorders in the EU.

Public health genomics

The EU health strategy affects the future of public health genomics Choose translations of the previous link български (bg) čeština (cs) dansk (da) Deutsch (de) eesti keel (et) ελληνικά (el) español (es) français (fr) italiano (it) latviešu valoda (lv) lietuvių kalba (lt) magyar (hu) Malti (mt) Nederlands (nl) polski (pl) português (pt) română (ro) slovenčina (sk) slovenščina (sl) suomi (fi) svenska (sv) , as it covers important areas which require the integration of genome-based knowledge and technologies